
| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Hepatitis C virus infection in Thai patients with oral lichen planus | Klanrit, P. Thongprasom, K. Poovorawan, Y. |
2003 | ||||
| 2. | Characterization of oral pemphigus vulgaris in Thai patients. | Boonyawong, P. Klanrit, P. Prasongtunskul, S. Thongprasom, K. |
2006 | ||||
| 3. | Inhibitory effect of Streblus asper leaf-extract on adhesion of Candida albicans to denture acrylic | Taweechaisupapong, S. Klanrit, P. Singhara, S. Pitiphat, W. Wongkham, S. |
2006 | ||||
| 4. | DNA ploidy in proliferative verrucous leukoplakia | Klanrit, P. | 2007 | ||||
| 5. | p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing | Klanrit, P. Lowe, S.W.S.W. |
2007 | ||||
| 6. | Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin | Klanrit, P. | 2008 | ||||
| 7. | Family at last: Highlights of the first international meeting on proteins killing tumour cells | Bruno, P. Brinkmann, C.R. Boulanger, M.C. Klanrit, P. Portsmouth, D. Zimmerman, R.M.E. |
2009 | ||||
| 8. | Immunohistochemical analyses of survivin and heat shock protein 90 expression in patients with oral lichen planus | Chaiyarit, P. Jintakanon, D. Klanrit, P. Siritapetawee, M. Thongprasom, K. |
2009 | ||||
| 9. | PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers | Klanrit, P. | 2009 | ||||
| 10. | Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and DNp73 isoforms through ubiquitin ligase PIR2 | Klanrit, P. | 2012 | ||||
| 11. | Increased immunoexpression of trefoil factors in salivary gland tumors | Chaiyarit, P. Klanrit, P. Photipakdee, P. Subarnbhesaj, A. Giraud, A.S. |
2014 | ||||
| 12. | Oral pyogenic granuloma presenting as an atypically large soft tissue mass: A case report | Limmonthol, S. Klanrit, P. |
2014 | ||||
| 13. | Oral and maxillofacial lesions in a Thai pediatric population: A retrospective review from two dental schools | Juengsomjit, R. Klanrit, P. Taweechaisupapong, S. Poomsawat, S. |
2015 | ||||
| 14. | Role of nanotechnology in development of artificial organs | Klanrit, P. | 2015 | ||||
| 15. | Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold | Klanrit, P. Chambers, R.C. |
2016 | ||||
| 16. | Biological functions of melatonin in relation to pathogenesis of oral lichen planus | Chaiyarit, P. Klanrit, P. Hormdee, D. |
2017 | ||||
| 17. | Increased melatonin in oral mucosal tissue of oral lichen planus (OLP) patients: A possible link between melatonin and its role in oral mucosal inflammation | Klanrit, P. Hormdee, D. Chaiyarit, P. |
2017 | ||||
| 18. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 | ||||
| 19. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 | ||||
| 20. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Thanee, M. Namwat, N. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Loilome, W. |
2020 | ||||
| 21. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 | ||||
| 22. | Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression | Thanan, R. Sakonsinsiri, C. Armartmuntree, N. Techasen, A. Klanrit, P. Lert-Itthiporn, W. Pinlaor, S. Pairojkul, C. |
2020 | ||||
| 23. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Thanee, M. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Saya, H. Loilome, W. |
2020 | ||||
| 24. | 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Phetcharaburanin, J. Moolpia, K. Suksawat, M. Promraksa, B. Klanrit, P. Namwat, N. Loilome, W. Poopasit, K. Katekaew, S. Phetcharaburanin, P. |
2020 | ||||
| 25. | A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples | Jamnongkan, W. Phetcharaburanin, J. Klanrit, P. Namwat, N. Techasen, A. Sithithaworn, P. Khuntikeo, N. Boonmars, T. Loilome, W. Ngeontae, W. |
2021 | ||||
| 26. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 | ||||
| 27. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Klanrit, P. Hanboonsong, Y. Yordpratum, U. Suksawat, M. Sermswan, R.W. Namwat, N. Loilome, W. Khampitak, T. Wangwiwatsin, A. Phetcharaburanin, J. |
2021 | ||||
| 28. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 | ||||
| 29. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 | ||||
| 30. | Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma | Phetcharaburanin, J. Namwat, N. Klanrit, P. Thanee, M. Dokduang, H. Loilome, W. |
2021 | ||||
| 31. | Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples | Taron, W. Jamnongkan, W. Techasen, A. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Boonmars, T. Sithithaworn, P. Buranachai, C. Loilome, W. Ngeontae, W. |
2021 | ||||
| 32. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Dokduang, H. Padthaisong, S. Namwat, N. Klanrit, P. Phetcharaburanin, J. Wangwiwatsin, A. Khampitak, T. Koonmee, S. Titapun, A. Khuntikeo, N. Loilome, W. |
2021 | ||||
| 33. | Antioxidant and Anticancer Potential of Bioactive Compounds from Rhinacanthus nasutus Cell Suspension Culture | Klanrit, P. Klanrit, P. Phetcharaburanin, J. Thanonkeo, P. Apiraksakorn, J. Klanrit, P. |
2022 | ||||
| 34. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 | ||||
| 35. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 | ||||
| 36. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 | ||||
| 37. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 | ||||
| 38. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia | Wangwiwatsin, A. Kulwong, S. Phetcharaburanin, J. Namwat, N. Klanrit, P. Loilome, W. Maleewong, W. Reid, A.J. |
2023 | Count | 38 | 0 | 0 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Hepatitis C virus infection in Thai patients with oral lichen planus | Klanrit, P. Thongprasom, K. Poovorawan, Y. |
2003 |
Oral Diseases 6 (9), pp. 292-297 |
||||||||
| 2. | Characterization of oral pemphigus vulgaris in Thai patients. | Boonyawong, P. Klanrit, P. Prasongtunskul, S. Thongprasom, K. |
2006 |
Journal of oral science 1 (48), pp. 43-46 |
||||||||
| 3. | Inhibitory effect of Streblus asper leaf-extract on adhesion of Candida albicans to denture acrylic | Taweechaisupapong, S. Klanrit, P. Singhara, S. Pitiphat, W. Wongkham, S. |
2006 |
Journal of Ethnopharmacology 3 (106), pp. 414-417 |
||||||||
| 4. | DNA ploidy in proliferative verrucous leukoplakia | Klanrit, P. | 2007 |
Oral Oncology 3 (43), pp. 310-316 |
||||||||
| 5. | p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing | Klanrit, P. Lowe, S.W.S.W. |
2007 |
Oncogene 48 (26), pp. 6863-6874 |
||||||||
| 6. | Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin | Klanrit, P. | 2008 |
Cell Cycle 2 (7), pp. 205-215 |
||||||||
| 7. | Family at last: Highlights of the first international meeting on proteins killing tumour cells | Bruno, P. Brinkmann, C.R. Boulanger, M.C. Klanrit, P. Portsmouth, D. Zimmerman, R.M.E. |
2009 |
Cell Death and Differentiation 1 (16), pp. 184-186 |
||||||||
| 8. | Immunohistochemical analyses of survivin and heat shock protein 90 expression in patients with oral lichen planus | Chaiyarit, P. Jintakanon, D. Klanrit, P. Siritapetawee, M. Thongprasom, K. |
2009 |
Journal of Oral Pathology and Medicine 1 (38), pp. 55-62 |
||||||||
| 9. | PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers | Klanrit, P. | 2009 |
Oncogene 39 (28), pp. 3499-3512 |
||||||||
| 10. | Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and DNp73 isoforms through ubiquitin ligase PIR2 | Klanrit, P. | 2012 |
Apoptosis 8 (17), pp. 762-776 |
||||||||
| 11. | Increased immunoexpression of trefoil factors in salivary gland tumors | Chaiyarit, P. Klanrit, P. Photipakdee, P. Subarnbhesaj, A. Giraud, A.S. |
2014 |
Clinical Oral Investigations 4 (18), pp. 1305-1312 |
||||||||
| 12. | Oral pyogenic granuloma presenting as an atypically large soft tissue mass: A case report | Limmonthol, S. Klanrit, P. |
2014 |
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2 (26), pp. 258-261 |
||||||||
| 13. | Oral and maxillofacial lesions in a Thai pediatric population: A retrospective review from two dental schools | Juengsomjit, R. Klanrit, P. Taweechaisupapong, S. Poomsawat, S. |
2015 |
Journal of the Medical Association of Thailand 3 (98), pp. 291-297 |
||||||||
| 14. | Role of nanotechnology in development of artificial organs | Klanrit, P. | 2015 |
Minerva medica 1 (106), pp. 17-33 |
||||||||
| 15. | Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold | Klanrit, P. Chambers, R.C. |
2016 |
Biomaterials (83), pp. 283-293 |
||||||||
| 16. | Biological functions of melatonin in relation to pathogenesis of oral lichen planus | Chaiyarit, P. Klanrit, P. Hormdee, D. |
2017 |
Medical Hypotheses (104), pp. 40-44 |
||||||||
| 17. | Increased melatonin in oral mucosal tissue of oral lichen planus (OLP) patients: A possible link between melatonin and its role in oral mucosal inflammation | Klanrit, P. Hormdee, D. Chaiyarit, P. |
2017 |
Archives of Oral Biology (78), pp. 13-19 |
||||||||
| 18. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 |
OncoTargets and Therapy (11), pp. 7019-7029 |
||||||||
| 19. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 |
PLoS ONE 9 (14), pp. |
||||||||
| 20. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Thanee, M. Namwat, N. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Loilome, W. |
2020 |
BMC Cancer 1 (20), pp. |
||||||||
| 21. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 |
Drug Design, Development and Therapy (14), pp. 2319-2334 |
||||||||
| 22. | Opposing roles of FoxA1 and FoxA3 in intrahepatic cholangiocarcinoma progression | Thanan, R. Sakonsinsiri, C. Armartmuntree, N. Techasen, A. Klanrit, P. Lert-Itthiporn, W. Pinlaor, S. Pairojkul, C. |
2020 |
International Journal of Molecular Sciences 5 (21), pp. |
||||||||
| 23. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Thanee, M. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Saya, H. Loilome, W. |
2020 |
Journal of Translational Medicine 1 (18), pp. |
||||||||
| 24. | <sup>1</sup>H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Phetcharaburanin, J. Moolpia, K. Suksawat, M. Promraksa, B. Klanrit, P. Namwat, N. Loilome, W. Poopasit, K. Katekaew, S. Phetcharaburanin, P. |
2020 |
PLoS ONE 12 December (15), pp. |
||||||||
| 25. | A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples | Jamnongkan, W. Phetcharaburanin, J. Klanrit, P. Namwat, N. Techasen, A. Sithithaworn, P. Khuntikeo, N. Boonmars, T. Loilome, W. Ngeontae, W. |
2021 |
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy (254), pp. |
||||||||
| 26. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 |
Naunyn-Schmiedeberg's Archives of Pharmacology 10 (394), pp. 2049-2059 |
||||||||
| 27. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Klanrit, P. Hanboonsong, Y. Yordpratum, U. Suksawat, M. Sermswan, R.W. Namwat, N. Loilome, W. Khampitak, T. Wangwiwatsin, A. Phetcharaburanin, J. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 28. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 |
PLoS ONE 3 March (16), pp. |
||||||||
| 29. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 |
Frontiers in Public Health (9), pp. |
||||||||
| 30. | Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma | Phetcharaburanin, J. Namwat, N. Klanrit, P. Thanee, M. Dokduang, H. Loilome, W. |
2021 |
Cancer Genomics and Proteomics 1 (18), pp. 29-42 |
||||||||
| 31. | Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples | Taron, W. Jamnongkan, W. Techasen, A. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Boonmars, T. Sithithaworn, P. Buranachai, C. Loilome, W. Ngeontae, W. |
2021 |
Sensors and Actuators B: Chemical (348), pp. |
||||||||
| 32. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Dokduang, H. Padthaisong, S. Namwat, N. Klanrit, P. Phetcharaburanin, J. Wangwiwatsin, A. Khampitak, T. Koonmee, S. Titapun, A. Khuntikeo, N. Loilome, W. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
| 33. | Antioxidant and Anticancer Potential of Bioactive Compounds from Rhinacanthus nasutus Cell Suspension Culture | Klanrit, P. Klanrit, P. Phetcharaburanin, J. Thanonkeo, P. Apiraksakorn, J. Klanrit, P. |
2022 |
Plants 15 (11), pp. |
||||||||
| 34. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 35. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 |
Frontiers in Pharmacology (13), pp. |
||||||||
| 36. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 37. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| 38. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia | Wangwiwatsin, A. Kulwong, S. Phetcharaburanin, J. Namwat, N. Klanrit, P. Loilome, W. Maleewong, W. Reid, A.J. |
2023 |
Frontiers in Microbiology (14), pp. |
||||||||
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|